Evexia Lifecare Ltd
Incorporated in 1990, Evexia Lifecare Ltd does trading of Chemicals, Agriculture Produce and other Consumer Goods[1]
- Market Cap ₹ 467 Cr.
- Current Price ₹ 2.49
- High / Low ₹ 4.40 / 2.07
- Stock P/E 640
- Book Value ₹ 2.32
- Dividend Yield 0.00 %
- ROCE 0.20 %
- ROE 0.27 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Stock is trading at 1.08 times its book value
- Company is expected to give good quarter
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -2.95% over past five years.
- Promoter holding is low: 3.49%
- Company has a low return on equity of 0.85% over last 3 years.
- Company has high debtors of 381 days.
- Promoter holding has decreased over last 3 years: -39.5%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.74 | 0.62 | 33.96 | 177.53 | 67.76 | 91.98 | 97.42 | 50.68 | 71.63 | 68.73 | 54.90 | 83.89 | |
1.10 | 0.67 | 34.00 | 176.26 | 68.19 | 92.33 | 103.41 | 122.92 | 69.29 | 67.17 | 53.35 | 81.99 | |
Operating Profit | -0.36 | -0.05 | -0.04 | 1.27 | -0.43 | -0.35 | -5.99 | -72.24 | 2.34 | 1.56 | 1.55 | 1.90 |
OPM % | -48.65% | -8.06% | -0.12% | 0.72% | -0.63% | -0.38% | -6.15% | -142.54% | 3.27% | 2.27% | 2.82% | 2.26% |
0.65 | 0.42 | 0.44 | 0.16 | 1.27 | 2.89 | 11.40 | 74.35 | 0.04 | 1.86 | 0.87 | 0.14 | |
Interest | 0.01 | 0.02 | 0.05 | 0.02 | 0.02 | 0.01 | 0.20 | 0.01 | 0.10 | 0.18 | 0.49 | 0.36 |
Depreciation | 0.21 | 0.20 | 0.08 | 0.08 | 0.18 | 0.32 | 0.31 | 0.24 | 0.21 | 0.39 | 0.42 | 0.47 |
Profit before tax | 0.07 | 0.15 | 0.27 | 1.33 | 0.64 | 2.21 | 4.90 | 1.86 | 2.07 | 2.85 | 1.51 | 1.21 |
Tax % | 14.29% | 33.33% | 37.04% | 32.33% | 31.25% | 30.32% | 28.98% | 32.26% | 61.84% | 30.18% | 23.84% | 39.67% |
0.07 | 0.10 | 0.16 | 0.90 | 0.45 | 1.54 | 3.48 | 1.25 | 0.80 | 1.99 | 1.15 | 0.73 | |
EPS in Rs | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.06 | 0.02 | 0.01 | 0.03 | 0.02 | 0.00 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 63% |
5 Years: | -3% |
3 Years: | 5% |
TTM: | 53% |
Compounded Profit Growth | |
---|---|
10 Years: | 22% |
5 Years: | -27% |
3 Years: | -3% |
TTM: | -37% |
Stock Price CAGR | |
---|---|
10 Years: | 8% |
5 Years: | -21% |
3 Years: | 13% |
1 Year: | 9% |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | 1% |
3 Years: | 1% |
Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6.45 | 46.45 | 61.93 | 61.93 | 61.93 | 61.93 | 61.93 | 61.93 | 61.93 | 66.44 | 70.80 | 187.73 |
Reserves | 47.21 | 18.78 | 3.41 | 3.81 | 11.30 | 12.86 | 16.36 | 17.59 | 18.42 | 24.91 | 34.10 | 246.95 |
2.54 | 4.66 | 7.62 | 6.01 | 5.90 | 4.79 | 5.83 | 6.70 | 5.65 | 694.61 | 682.78 | 374.17 | |
4.03 | 3.59 | 35.40 | 147.02 | 126.90 | 142.13 | 138.48 | 52.51 | 38.81 | 49.99 | 64.56 | 55.42 | |
Total Liabilities | 60.23 | 73.48 | 108.36 | 218.77 | 206.03 | 221.71 | 222.60 | 138.73 | 124.81 | 835.95 | 852.24 | 864.27 |
2.84 | 2.40 | 2.28 | 2.30 | 8.90 | 8.62 | 8.94 | 8.84 | 8.96 | 10.98 | 10.72 | 10.52 | |
CWIP | 0.02 | 0.02 | 0.20 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 2.13 | 0.00 | 0.00 | 0.00 |
Investments | 3.14 | 3.55 | 1.51 | 0.52 | 0.07 | 0.07 | 0.07 | 0.93 | 0.92 | 698.81 | 698.81 | 708.81 |
54.23 | 67.51 | 104.37 | 215.75 | 197.06 | 213.02 | 213.59 | 128.96 | 112.80 | 126.16 | 142.71 | 144.94 | |
Total Assets | 60.23 | 73.48 | 108.36 | 218.77 | 206.03 | 221.71 | 222.60 | 138.73 | 124.81 | 835.95 | 852.24 | 864.27 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-2.77 | 4.09 | 10.85 | 10.02 | -13.16 | -1.29 | -1.67 | 3.96 | -4.88 | -2.53 | -2.18 | -5.93 | |
-2.41 | 0.22 | 2.33 | 2.33 | -5.15 | 0.02 | 1.92 | -4.71 | 5.68 | -697.42 | 2.22 | -14.51 | |
5.14 | -3.63 | -12.27 | -12.27 | 17.74 | 1.44 | -0.37 | 0.88 | -0.03 | 698.90 | 0.27 | 20.08 | |
Net Cash Flow | -0.04 | 0.68 | 0.91 | 0.08 | -0.57 | 0.16 | -0.11 | 0.13 | 0.77 | -1.05 | 0.32 | -0.36 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 1,030.88 | 983.15 | 236.99 | 286.42 | 179.65 | 217.22 | 254.81 | 327.33 | 60.28 | 151.30 | 272.19 | 380.53 |
Inventory Days | 180.00 | 197.30 | 4.70 | 1.64 | 2.85 | 2.12 | 2.14 | 0.46 | 2.07 | 6.30 | 3.43 | 9.49 |
Days Payable | 85.00 | 187.43 | 383.14 | 73.29 | 70.75 | 173.54 | 175.97 | 224.85 | 121.21 | 177.47 | 178.63 | 248.55 |
Cash Conversion Cycle | 1,125.88 | 993.01 | -141.45 | 214.77 | 111.75 | 45.80 | 80.98 | 102.94 | -58.86 | -19.87 | 96.98 | 141.47 |
Working Capital Days | 1,178.85 | -1,577.74 | 205.07 | 250.48 | 305.15 | 157.34 | 269.72 | 452.22 | 214.83 | 244.45 | 400.37 | 170.17 |
ROCE % | 0.25% | 0.27% | 0.45% | 1.87% | 0.87% | 2.80% | 6.23% | 2.25% | 2.52% | 0.69% | 0.25% | 0.20% |
Documents
Announcements
-
Revised Outcome Of The Board Meeting Held On May 30,2025
31 May - Audited FY25 financials approved; qualified audit report; new independent director appointed for 5 years.
- Financial Year For The FY24-25 31 May
-
Appointment Of Independent Director In The Company
30 May - Audited FY25 results approved; qualified audit report; new independent director appointed for 5 years.
-
Announcement under Regulation 30 (LODR)-Change in Management
30 May - Audited FY25 results with qualified audit report; appointed Ms. Mehta as independent director for 5 years.
-
Financial Results For FY 24-25
30 May - Q4 and FY25 audited results with qualified audit; appointed independent director for 5 years.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company manufactures various petrochemical downstream products viz. special oils, special chemicals, petroleum sulphates and solvents
for industrial applications, such as rubber,
leather, ink and paint industries